Recent Quotes

Bellerophon Therapeutics Inc is a clinical-stage biotherapeutics company. The firm develops innovative products combining novel drugs and devices to treat cardiopulmonary diseases. It develops products under its INOpulse platform, which is an extension of the technology that is used in hospitals to deliver continuous-flow inhaled nitric oxide. The company products are aimed at the treatment of different kinds of pulmonary hypertension.

Earnings

Q2 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-08-09
REV		(EXPECTED)2021-08-09

Q1 2021		Est.		Actual		Surprise
EPS		-0.690		-0.580		0.1100
REV				0

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
BLPH	Bellerophon Therapeutics	4.51	0.19	4.4%		42.9M

Bellerophon Therapeutics Frequently Asked Questions

How do I buy Bellerophon Therapeutics (BLPH) stock?

You can purchase shares of Bellerophon Therapeutics (NASDAQ: BLPH) through any online brokerage.

View our list of the best stock brokerages.

Who are Bellerophon Therapeutics's (BLPH) competitors?

Other companies in Bellerophon Therapeutics’s space includes: Ekso Bionics Holdings (NASDAQ:EKSO), Strata Skin Sciences (NASDAQ:SSKN), Biomerica (NASDAQ:BMRA), Motus GI Hldgs (NASDAQ:MOTS) and Medigus (NASDAQ:MDGS).

What is the target price for Bellerophon Therapeutics (BLPH) stock?

The latest price target for Bellerophon Therapeutics (NASDAQ: BLPH) was reported by Jefferies on August 11, 2020. The analyst firm set a price target for 19.00 expecting BLPH to rise to within 12 months (a possible 321.29% upside). 1 analyst firms have reported ratings in the last year.

Current Stock Price for Bellerophon Therapeutics (BLPH)?

The stock price for Bellerophon Therapeutics (NASDAQ: BLPH) is $4.51 last updated Today at 6:58:22 PM.

Does Bellerophon Therapeutics (BLPH) pay a dividend?

There are no upcoming dividends for Bellerophon Therapeutics.

When is Bellerophon Therapeutics (NASDAQ:BLPH) reporting earnings?

Bellerophon Therapeutics’s Q2 earnings are confirmed for after-market on August 9, 2021.

Is Bellerophon Therapeutics (BLPH) going to split?

There is no upcoming split for Bellerophon Therapeutics.

What sector and industry does Bellerophon Therapeutics (BLPH) operate in?

Bellerophon Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.